ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.56
      0.24%
      US Tech 100
      19,410.00
      0.46%
      Dow Jones
      42,164.07
      0.09%
      Brent Oil
      74.415
      0.92%
      Bitcoin
      63,398.16
      0.11%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Supergen, Inc. (MM) (SUPG) Quote

      Supergen, Inc. (MM)

      Supergen, Inc. (MM) (SUPG)

      NASDAQ
      2.03
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.03
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      2.03
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      SUPG Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      4 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      5 hours ago

      SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference as Astex Pharmaceuticals, Inc. on September 12th

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D...

      September 02 2011
      Business Wire

      SuperGen Reports 2011 Second Quarter Financial Results

      SuperGen, Inc. (NASDAQ: SUPG) today reported financial results for the second quarter ended June 30, 2011. The Company reported net income for the 2011 second quarter of...

      August 03 2011
      Business Wire

      SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011

      SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2011 second quarter...

      July 22 2011
      Business Wire

      SuperGen Completes Acquisition of Astex Therapeutics

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it has closed the transaction to acquire...

      July 20 2011
      Business Wire

      FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information...

      July 13 2011
      Business Wire

      SuperGen President & CEO Elected to BIO Board of Directors

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that its chairman, president and chief...

      June 28 2011
      Business Wire

      SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that stockholders have approved the...

      June 16 2011
      Business Wire

      SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

      SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com Company invites individual and institutional investors to log-on to view its President and CEO...

      June 06 2011
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 8.158
      (94.24%)
      		50.4M
      MSSMaison Solutions Inc
      $ 1.3689
      (91.45%)
      		78.03M
      SEELSeelos Therapeutics Inc
      $ 0.3341
      (75.84%)
      		302.65M
      WVEWave Life Sciences Ltd
      $ 8.20
      (53.56%)
      		10.81M
      XHGXChange TED Inc
      $ 0.9425
      (52.14%)
      		21.98M
      BIVIBioVie Inc
      $ 1.23
      (-56.07%)
      		1.9M
      GHSIGuardion Health Sciences Inc
      $ 6.64
      (-36.88%)
      		287.33k
      XPONExpion360 Inc
      $ 0.0896
      (-23.42%)
      		34.17M
      VEROVenus Concept Inc
      $ 0.62
      (-22.67%)
      		346.41k
      VEEAVeea Inc
      $ 7.6568
      (-21.87%)
      		125.63k
      SEELSeelos Therapeutics Inc
      $ 0.3341
      (75.84%)
      		302.65M
      NVDANVIDIA Corporation
      $ 121.2256
      (4.27%)
      		205.59M
      SQQQProShares UltraPro Short QQQ
      $ 7.6401
      (-1.67%)
      		95.78M
      MLGOMicroAlgo Inc
      $ 0.2224
      (12.10%)
      		82.2M
      MSSMaison Solutions Inc
      $ 1.3689
      (91.45%)
      		78.03M

      Discussion

      View Full Feed
      delerious1 delerious1 2 minutes ago
      Is this why we're up 14% today....not a bad increase in a day
      RONN
      zeusgodmd zeusgodmd 3 minutes ago
      3 million in play
      RNAZ
      harr449 harr449 3 minutes ago
      Form 10-K today counter acted good news.

      Price dropping.
      SEEL
      harr449 harr449 3 minutes ago
      Form 10-K today counter acted good news.

      Price dropping.
      SEEL
      Groveman1 Groveman1 3 minutes ago
      Wonder what the Motivation is to want to trash a stock over 20,000 times in someones lifetime. What's that old saying, Get A Life.
      BIEL
      thistraderknowsall thistraderknowsall 3 minutes ago
      BREAKOUT!!! ACH altcoin just got a $5 target runup on latest developments!!! We rich!!!
      varmit varmit 3 minutes ago
      Goon ide rather bee stupid than an idiot like ewe . Sucks to bee a sheep !!!!
      RNVA
      dennisdave dennisdave 3 minutes ago
      That's why I blocked that guy ages ago. The zealot cult size of that guy is unbearable. Powers could puke in a bucket and he would explain it as a newfound goldmine.
      NWBO
      xoom xoom 3 minutes ago
      Other priorities like ‘fixing ceiling fans’ ?
      COOP
      NYBob NYBob 3 minutes ago
      Aris Mining’s Presentation at the 2024 Denver Gold Forum

      Here is the Aris Mining Presentation that CEO Neil Woodyer made at the Denver Gold Forum on September 16th.


      https://www.goldforumamericas.com/company-session/3425/
      ARMN
      georgie18 georgie18 3 minutes ago
      VINE...669...Off the .28 spot...🥳
      Nebuchadnezzar Nebuchadnezzar 4 minutes ago
      i guess i am just surprised. I thought all the best news and 200 bips in rate cuts were priced into the market already with Sp 500 at 5700
      and NASDAQ futures at 20000 and many other stocks at record highs

      i just dont see the returns from here from a mathematical viewpoint
      AAPL MSFT NVDA
      Top Penny Top Penny 4 minutes ago
      Buying
      MHRE
      pinkslipjunkie pinkslipjunkie 4 minutes ago
      You are right but at the same time many companies use it as a pumping tool of things that never manifest...now Mr Roth not saying that is the case with ASII and my comment was more of a general statement and not really pertaining specifically to ASII....and I do currently own shares of ASII....so at
      ASII
      Gmenfan Gmenfan 4 minutes ago
      Yep, this is unusual for me.
      DaJester DaJester 4 minutes ago
      I haven't seen the clip, but wouldn't surprise me. The big deception was that they needed aid to begin with after passing all the stress tests. Now it's just assumed that they did need the original bailout, and that the actions of FHFA/Treasury since then were "helpful"... Clearly not the case to an
      FNMA
      PennyMillions852 PennyMillions852 4 minutes ago
      This is THIN!!!!!!!!!!!!!🚀🚀🚀 matter of time!!
      IGPK
      WALLnut WALLnut 4 minutes ago
      Indeed, Approval coming soon.

      I loaded 2 of these monster trucks....Belaz 75710. Ha!

      And no dumping til at least $1.89. But most after $4.



      RDGL
      RDGL
      georgie18 georgie18 4 minutes ago
      VINE...669...Off the .28 alert...🥳

      georgie18

      Member Level
      Re: georgie18 post# 656576

      Thursday, September 12, 2024 10:56:14 AM

      Post#
      657299
      of 659132
      VINE...56s clearing here...🥳...off mt .28 ra
      VINE
      georgie18 georgie18 5 minutes ago
      VINE...669...Off the .28 alert...🥳

      georgie18

      Member Level
      Re: georgie18 post# 656576

      Thursday, September 12, 2024 10:56:14 AM

      Post#
      657299
      of 659132
      VINE...56s clearing here...🥳...off mt .28 ra
      Pablo Bandito Pablo Bandito 5 minutes ago
      Its crazy that the guy who played futbol with his familys heads may have misled everyone about this company
      ASTA
      kund kund 6 minutes ago
      SAVA recovered all yesterday's loss but this POS has no volume. Hope this don't become next BIVI.
      BIVI
      stockyupydowny stockyupydowny 6 minutes ago
      Still here and holding... have not sold anything ... tick tock and patience.... MJ has a strong year ahead 2025 for the win!
      BLEG
      Fire_starter Fire_starter 6 minutes ago
      CHECK OUT L2 NOW
      RNAZ
      ProfitScout ProfitScout 6 minutes ago
      $NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

      "How NRx Could Upend the Fight Against Depression and Suicide"

      RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical compa
      NRXP

      Your Recent History

      NASDAQ
      SUPG
      Delayed Upgrade Clock